T ü bingen study raises hope for effective malaria vaccine

(German Center for Infection Research) At the University Hospital of Tuebingen, a clinical trial led by Prof. Dr. Peter Kremsner, Director of the Institute of Tropical Medicine and Dr. Rolf Fendel, Research Group Leaderat the Institute of Tropical Medicine partnered with the German Center for Infection Research (DZIF), was able to show that the vaccine, " Sanaria ® PfSPZ-CVac " , which is being developed in Tuebingen together with the biotechnology company Sanaria Inc., provides 77 percent cross-strain protection against malaria parasites.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news